Economic Pricing & Portability Account for Sustained Sales of TENS Devices
Transcutaneous Electric Nerve Stimulator (TENS) covers a complete range of transcutaneously applied currents used for nerve excitation. This device can be used in acute as well as long term treatment methods, targeting the patients of osteoporosis-related joint pain, neck pain, bone or muscle problems, tendinitis, cancer pain, bursitis, sciatica pain, and diabetic neuropathy.
Increasing adoption of TENS devices for radiating pain and growing popularity of portable TENS devices in treating limbs pain will reportedly continue to push their dominance in muscle stimulation devices market.
Patients with cervical and lumber spondylosis, and sciatica are preferring non-invasive electrotherapy modalities such as TENS over conventional therapy methods. As these devices efficiently provide pain relief without side effects, they are anticipated to witness high patient preference.
A growing number of companies in the market are concentrating on catering to bolstering demand for cheaper, portable single unit TENS devices, which are used to address radiating pain in home care settings.
Neuromuscular Electric Stimulator (NMES) are commonly used to retrain a muscle to function, strengthening it post surgery. NMES sales will reportedly remain steady, prominently to regulate edema, increase local blood circulation, maintain muscle tone, and retard the development of disease atrophy.
Interferential (IF) therapy is widely used to treat pain associated with sports injuries, joint injuries, edema, back, neck, shoulder, and knee injuries or other problems, fibromyalgia, carpal tunnel syndrome, and tennis elbow.
Burst Mode Alternating Current (BMAC) is used to strengthen muscles and muscular re-education. It also stimulates analgesic effect in the muscles, resulting in effective pain reduction along with increased muscular strength.
The global revenue of muscle stimulation devices market is expected to expand passively, at a CAGR of 3.9% over 2018-2028. The US$ 575 million market will barely reach beyond US$ 870 million by the end of 2028. As indicated by recent forecast, BMAC is expected to be an attractive area for manufacturers during the assessment period.
Combination Devices to Become Evidently Popular in Asian Countries
Combination therapy using IFT, US, and MS devices has been trending the market, especially for joint pain and lower back pain. While IFT machines have been in use for chronic joint pain and lower back pain resultant from osteoarthritis (OA), a considerable portion of the expanding OA patient pool in Asia Pacific is preferring this combined device therapy over conventional treatments. A majority of companies in APAC are thus expected to target hospitals and physiotherapy clinics, for augmenting portable combination device sales.
Swelling Demand in Sports Medicine to Spur Adoption of EMS Devices
Electrical muscle stimulation devices have been used by sports professionals over the years, during the warm-up sessions in gyms. Besides widespread use in pre-endurance training, EMS devices are used during the cooling down sessions post-training. The ultimate aim is to prevent muscle soreness through muscle stimulation and causing soft contractions on a group of muscles, after a vigorous activity.
Soaring Use for Rehabilitation of Atrophied Muscles Post-stroke, to Increase Sales
As physiotherapists are increasingly preferring galvanic stimulators or EMS devices to revive atrophied muscles in stroke or spinal multiple sclerosis patients, in terms of strength, the market is most likely to benefit in terms of revenue through 2028.
These devices have been in use for lower limb muscle rehabilitation and upper limb strengthening, which apparently assists in gait training for the stroke patients. Moreover, adoption of muscle stimulators will also remain on a steady rise for treating Bell’s palsy patients, as these devices are highly popular among paralytic patients for long-term home therapy.
Market Segmentation
On the basis of region, the global muscle stimulation devices market is segmented into:
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Rest of Latin America
Western Europe
- Germany
- Italy
- France
- Spain
- U.K.
- Benelux
- Nordic
- Rest of Western Europe
Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
Asia Pacific Excluding Japan
- India
- China
- ASEAN
- Australia & New Zealand
- Rest of APEJ
Japan
Middle East & Africa (MEA)
The next section analyses market on the basis of product type and presents forecast in terms of value (US$ Mn) for the next 10 years. Product types included in the report are-
- Neuromuscular Electric Stimulator (NMES)
- Transcutaneous Electric Nerve Stimulator (TENS)
- Interferential (If)
- Burst Mode Alternating Current
The next section analyses market on the basis of indication and presents forecast in terms of value (US$ Mn) for the next 10 years The global muscle stimulation devices market is segmented on the basis of application into:
- Pain Management
- Neurological & Movement Disorder Management
- Musculoskeletal Disorder Management
The next section analyses the market on the basis of the end user and presents forecast in terms of value (US$ Mn) for the next 10 years. On the basis of the end user, the global muscle stimulation devices market is categorized into:
- Hospitals
- Physiotherapy Clinics
- Sports Clinics
- Home Care Settings
Need specific information?
In the news
by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights
Our Clients
View Our Reports from Healthcare
View Reports